Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD

Massachusetts General Hospital50 enrolled

Overview

The primary objective is to establish the concurrent validity of the clinician administered Attention Deficit Hyperactivity Disorder-Rating Scale (ADHD-RS) and the patient administered Attention Deficit Hyperactivity Disorder Self Report Scale (ASRS) v1.1 Symptom Checklist.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Eligibility

Sex: ALLMin age: 13 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of ADHD * Age 13-65\* \*Parental consent and patient's assent will be obtained for minors participating in this protocol (only adolescents aged 13-18 yrs old will be included in the MGH site) Exclusion Criteria: * Inability to reliably report ADHD symptoms at the discretion of the investigator

Locations (1)

Massachusetts General Hospital

Cambridge, Massachusetts, United States

Outcomes

Primary Outcomes

The ADHD-RS and ASRS v1.1 Symptom Checklist scales

Time frame: Weeks 1, 2, 3, 4, 5, 6, 7, or 8

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.